Records containing: Myelofibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-10-24A Single-arm, Single Center, Pilot Study of Siltuximab, an Anti-IL6 Therapy, for Patients With Myelofibrosis
-
CLINICAL_TRIALS study record update · 2016-08-12Ruxolitinib in Combination With High Dose Therapy and Autologous Stem Cell Transplantation for Myelofibrosis
-
CLINICAL_TRIALS study record update · 2016-05-02Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
-
CLINICAL_TRIALS study record update · 2016-04-20Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
-
CLINICAL_TRIALS study record update · 2016-03-08A Phase I Clinical Study of CWP232291 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome Having Failed Hypomethylating Treatment, and High-Risk Myelofibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-02-26Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent GVHD After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
-
CLINICAL_TRIALS study record update · 2016-01-14Allogeneic Stem Cell Transplantation After Dose-reduced Intensity Conditioning Regimen for Patients With Myelofibrosis With Myeloid Metaplasia (MMM): A Phase II-study
-
CLINICAL_TRIALS study record update · 2014-12-09A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)
-
CLINICAL_TRIALS study record update · 2014-11-26A Multicenter, Open Label Phase I/II Study of CEP-701 (Lestaurtinib) in Adults With Myelofibrosis
-
CLINICAL_TRIALS study record update · 2014-08-28Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
-
CLINICAL_TRIALS study record update · 2014-08-22Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis
-
CLINICAL_TRIALS study record update · 2014-05-16Total Body Irradiation With Fludarabine Conditioning Followed by Transplantation With Combined Umbilical Cord Blood Grafts
-
CLINICAL_TRIALS study record update · 2013-10-28A Phase 2, Prospective, Randomized, Multicenter, Double-blind, Active-control, Parallel-group Study to Determine the Safety of and to Select a Treatment Regimen of CC-4047 (Pomalidomide) Either as Single-agent or in Combination With Prednisone to Study Further in Subjects With Myelofibrosis With Myeloid Metaplasia
-
CLINICAL_TRIALS study record update · 2013-09-25An Open-label Assessment of Once-daily Dosing of a Sustained Release (SR) Formulation of INCB018424 in Patients With Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, and Post-polycythemia Vera Myelofibrosis
-
CLINICAL_TRIALS study record update · 2013-08-26A Multi-Center, Open-Label, Phase II Study of Single-Agent GX15-070MS Administered as a 24-Hour Infusion Every 2 Weeks to Patients With Myelofibrosis With Myeloid Metaplasia (MF)
-
CLINICAL_TRIALS study record update · 2013-07-02A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2012-12-07A Phase II Study of Parathyroid Hormone Following Myeloablative Sequential Unrelated Cord Blood Transplantation
-
CLINICAL_TRIALS study record update · 2012-08-02A Phase 1/2, Open-Label Study of the JAK2 Inhibitor INCB018424 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (Post-PV/ET)
-
CLINICAL_TRIALS study record update · 2012-05-30A Randomized Study of Ruxolitinib Tablets Compared to Best Available Therapy in Subjects With Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis
-
CLINICAL_TRIALS study record update · 2012-04-20A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies
-
CLINICAL_TRIALS study record update · 2012-04-20A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
-
CLINICAL_TRIALS study record update · 2012-03-20In-Vivo Activated T-Cell Depletion to Prevent GVHD
-
CLINICAL_TRIALS study record update · 2011-05-04Evaluation of CEP-701, an Orally Available JAK2 Tyrosine Kinase Inhibitor, as a Therapy for Patients With Myelofibrosis
-
CLINICAL_TRIALS study record update · 2011-05-02A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators
-
CLINICAL_TRIALS study record update · 2011-04-28Creation of Bone Marrow Microenvironment for Treatment of MDS in Conjunction With Allogeneic Stem Cell Transplantation